Found: 15
Select item for more details and to access through your institution.
Selbstanordnung von BODIPY‐Farbstoffen als Werkzeug, um die Antitumoraktivität von Capsaicin bei Prostatakrebs zu erhöhen.
- Published in:
- Angewandte Chemie, 2018, v. 130, n. 52, p. 17481, doi. 10.1002/ange.201804783
- By:
- Publication type:
- Article
Hierarchical Self‐Assembly of BODIPY Dyes as a Tool to Improve the Antitumor Activity of Capsaicin in Prostate Cancer.
- Published in:
- Angewandte Chemie International Edition, 2018, v. 57, n. 52, p. 17235, doi. 10.1002/anie.201804783
- By:
- Publication type:
- Article
Low‐density lipoprotein receptor (LDLR) is an independent adverse prognostic factor in acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. 494, doi. 10.1111/bjh.16853
- By:
- Publication type:
- Article
Fragmentation of intra-peptide and inter-peptide disulfide bonds of proteolytic peptides by nanoESI collision-induced dissociation.
- Published in:
- Analytical & Bioanalytical Chemistry, 2008, v. 392, n. 5, p. 831, doi. 10.1007/s00216-008-2258-7
- By:
- Publication type:
- Article
Fragmentation of intra-peptide and inter-peptide disulfide bonds of proteolytic peptides by nanoESI collision-induced dissociation.
- Published in:
- Analytical & Bioanalytical Chemistry, 2008, v. 392, n. 5, p. 831, doi. 10.1007/s00216-008-2258-7
- By:
- Publication type:
- Article
Alternative targeting of Arabidopsis plastidic glucose-6-phosphate dehydrogenase G6PD1 involves cysteine-dependent interaction with G6PD4 in the cytosol.
- Published in:
- Plant Journal, 2011, v. 66, n. 5, p. 745, doi. 10.1111/j.1365-313X.2011.04535.x
- By:
- Publication type:
- Article
Multiparametric Magnetic Resonance Imaging for Immediate Target Hit Assessment of CD13—Targeted Tissue Factor tTF-NGR in Advanced Malignant Disease.
- Published in:
- Cancers, 2021, v. 13, n. 23, p. 5880, doi. 10.3390/cancers13235880
- By:
- Publication type:
- Article
Targeting Tissue Factor to Tumor Vasculature to Induce Tumor Infarction.
- Published in:
- Cancers, 2021, v. 13, n. 11, p. 2841, doi. 10.3390/cancers13112841
- By:
- Publication type:
- Article
Animal Safety, Toxicology, and Pharmacokinetic Studies According to the ICH S9 Guideline for a Novel Fusion Protein tTF-NGR Targeting Procoagulatory Activity into Tumor Vasculature: Are Results Predictive for Humans?
- Published in:
- Cancers, 2020, v. 12, n. 12, p. 3536, doi. 10.3390/cancers12123536
- By:
- Publication type:
- Article
First-In-Class CD13-Targeted Tissue Factor tTF-NGR in Patients with Recurrent or Refractory Malignant Tumors: Results of a Phase I Dose-Escalation Study.
- Published in:
- Cancers, 2020, v. 12, n. 6, p. 1488, doi. 10.3390/cancers12061488
- By:
- Publication type:
- Article
Radiation synergizes with antitumor activity of CD13-targeted tissue factor in a HT1080 xenograft model of human soft tissue sarcoma.
- Published in:
- PLoS ONE, 2020, v. 15, n. 2, p. 1, doi. 10.1371/journal.pone.0229271
- By:
- Publication type:
- Article
Nanoparticles that communicate in vivo to amplify tumour targeting.
- Published in:
- Nature Materials, 2011, v. 10, n. 7, p. 545, doi. 10.1038/nmat3049
- By:
- Publication type:
- Article
Gadofosveset-enhanced MRI as simple surrogate parameter for real-time evaluation of the initial tumour vessel infarction by retargeted tissue factor tTF-NGR.
- Published in:
- Oncology Letters, 2019, v. 17, n. 1, p. 270
- By:
- Publication type:
- Article
Correction: Potential therapeutic impact of CD13 expression in non-small cell lung cancer.
- Published in:
- 2017
- By:
- Publication type:
- Correction Notice
Potential therapeutic impact of CD13 expression in non-small cell lung cancer.
- Published in:
- PLoS ONE, 2017, v. 12, n. 6, p. 1, doi. 10.1371/journal.pone.0177146
- By:
- Publication type:
- Article